Global Grand Challenges is inviting applications for the Innovations for Improving the Impact of Health Campaigns at Bill and Melinda Gates Foundation in the USA 2020.
Countries rely on both routine health systems and campaign-based delivery to extend the reach of important health interventions such as accelerated disease control and delivery of life-saving health products and services. Many programs, including immunization, neglected tropical diseases, nutrition, malaria, and polio regularly rely on such campaigns to manage the spread of disease and achieve large scale health impact.
Campaign-based delivery of health interventions is typically time-limited, targeted, and implemented at scale. All countries utilize health campaigns in some capacity – such as outbreak response – and campaigns have shown to be an effective way of driving health impact.
Worth of Award
They will consider funding for:
- Proposals presenting clear innovation for improving the planning, implementation, or evaluation of health campaigns.
- Approaches that would not require a donor’s long-term financial support to sustain.
- Innovative ideas that repeat conventional approaches without novel application.
- Secondary analysis of existing studies or systematic reviews unless there is a clear way in which the analysis can be scaled and will fundamentally change practice.
- Approaches for which proof of concept can be demonstrated within the scope of the GCE Phase 1 award ($100,000 over 18 months).
- Approaches directly relevant to low-income settings.
- Proposals seeking to apply existing tools in ways that transform the current practices used for campaign-based delivery.
Criteria for success include solutions that:
- Are transformative, novel, or innovative. These interventions will significantly change the way in which campaigns are planned, conducted, or evaluated by proposing new ways of working, leveraging lessons from other sectors, or increasing transparency and effectiveness.
- Could be used by various health campaigns beyond the campaign in which the innovation is originally conceptualized or tested, such as for immunization (measles, yellow fever, meningitis, etc.), neglected tropical diseases (trachoma, onchocerciasis, schistosomiasis etc.), nutrition (vitamin A, deworming), malaria (bed net distribution, seasonal malaria chemoprophylaxis), and polio.
- Could be used in various low- and middle-income countries beyond the country in which the innovation is originally conceptualized or tested.
- Can be designed, tested, and scaled as a “best practice”.
- Can be applied in low- and middle-income countries.
- Are cost-effective.
How to Apply
Applications are online. Visit the website and apply.
Deadline: Application closes November 13, 2019 – 11:30 AM PST